BD Names William 'Bill' Brown to Board of Directors
BD (Becton, Dickinson and Company) has appointed William "Bill" Brown to its board of directors effective February 28, 2022. Brown, an experienced executive, is currently the executive chair of L3Harris Technologies with $18 billion in annual revenue. He previously served as chair and CEO of L3Harris from July 2019 to June 2021. BD's chairman, Tom Polen, expressed confidence in Brown's leadership skills to support the company's BD2025 strategy aimed at long-term stakeholder value. Having degrees in engineering and an MBA, Brown also holds several board positions.
- Appointment of Bill Brown brings extensive experience in operational excellence and innovation.
- Brown's leadership is expected to support the advancement of BD's BD2025 strategy.
- None.
FRANKLIN LAKES, N.J., March 1, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of William "Bill" Brown to its board of directors, effective Feb. 28, 2022.
Brown, 59, is currently the executive chair of L3Harris Technologies, a global aerospace and technology innovator with
"I am very pleased to welcome Bill to the BD Board of Directors," said Tom Polen, chairman, CEO and president of BD. "Bill is a growth-oriented leader with an extensive background in innovation and operational excellence. He will be a tremendous asset to our board and to BD as we continue to advance our BD2025 strategy and build sustainable, long-term value for our stakeholders."
Brown serves on the Celanese Corporation Board of Directors, the Fire Department of New York City Foundation Board and is a member of the Business Council. He is also the former chair of the Aerospace Industries Association (AIA) and was a member of AIA's Executive Committee.
Brown received his Bachelor and Master of Science degrees in mechanical engineering from Villanova University and a Master of Business Administration from the Wharton School of the University of Pennsylvania.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 75,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.
Contacts: | |
Media: | Investors: |
Troy Kirkpatrick | Francesca DeMartino |
VP, Public Relations | SVP, Head of Investor Relations |
858.617.2361 | 201.847.5743 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bd-names-william-bill-brown-to-board-of-directors-301493369.html
SOURCE BD (Becton, Dickinson and Company)
FAQ
Who is the new board member appointed at BDX?
What is William Brown's background?